Pharmaniaga's foray into Myanmar opens doors


KUALA LUMPUR: Pharmaniaga Bhd's successful foray into Myanmar with its Sinovac Covid-19 vaccine bodes well for its strategy to expand its vaccine distribution business beyond the local sector.

The pharmaceuticals group announced on Monday it had successfully exported the first batch of fill-finish Sinovac Covid-19 vaccines to Myanmar, manufactured by its wholly owned subsidiary Pharmaniaga Lifescience Sdn Bhd.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Property market recovery on the horizon
Meta projects higher spending, weaker revenue
Buyout proposal for Anglo American could reshape copper market
Bank asset values in UK face 5% hit this decade
AI memory boom propels SK Hynix’s numbers
Congo accuses Apple of using ‘blood minerals’ from war-torn east
NYCB faces tough choices on CRE loans, balance sheet diversification
Airlines must now provide automatic refunds for cancelled flights
Ford profit up on sales of commercial vehicles
Wall St set to open lower as Meta Platforms, economic data weigh

Others Also Read